Cytogenetic abnormalities in chronic B-cell lymphoproliferative disorders in Chinese patients

Area of Science:

• Hematology
• Cytogenetics
• Oncology

Background:

• Chronic B-cell lymphoproliferative disorders are a group of hematologic malignancies.
• Cytogenetic abnormalities play a crucial role in the diagnosis and prognosis of these disorders.
• Previous studies suggested a lower incidence of certain abnormalities, like trisomy 12, in Chinese populations.

Purpose of the Study:

• To investigate the spectrum of cytogenetic findings in Chinese patients diagnosed with chronic B-cell lymphoproliferative disorders.
• To determine the frequency of specific chromosomal abnormalities, including trisomy 12 and t(11;14), in this cohort.
• To compare the observed cytogenetic profiles with those reported in Western populations.

Main Methods:

• Karyotyping was performed on bone marrow or peripheral blood samples from 59 Chinese patients.
• Patients were diagnosed with various chronic B-cell lymphoproliferative disorders, including chronic lymphocytic leukemia and mantle cell lymphoma.
• Statistical analysis was used to determine the frequency of cytogenetic abnormalities.

Main Results:

• Cytogenetic abnormalities were detected in 44.1% of the 59 patients.
• Trisomy 12 was the most frequent abnormality in chronic lymphocytic leukemia (27.8% of cases).
• Structural abnormalities at chromosome 13q14 were also common in chronic lymphocytic leukemia. The t(11;14) translocation was observed in 18.2% of mantle cell lymphoma cases.

Conclusions:

• The incidence of trisomy 12 in Chinese patients with chronic lymphocytic leukemia may not be lower than in Western populations.
• The study identified common and unusual cytogenetic abnormalities in Chinese patients with B-cell lymphoproliferative disorders.
• These findings contribute to understanding the genetic landscape of these diseases in diverse ethnic groups.